Welcome to GeneBlue Corporation

welcome to GeneBlue Corporation Elevate our quality of life through scientific innovation and pharmaceutical devleopment

GeneBlue is an innovative biotechnology company committed to developing cutting edge technology and innovative mecidines that will alleviate the suffering associted with debilitating and life threatening diseases.

We currently focus on introducing effective and low toxic anti-cancer drugs and superiorly designed Rheumatoid Arthritis drugs. Total product related market reaches $16.6 billion.

11/13/2010
11/13/2010The new officer of Geneblue were elected for 2010 year and issue discussed relating Geneblue path to funding and brighten for future success for drug development
11/02/2010
Geneblue Board of Directors re-elected October 15th, 2010. The shareholder initiated re-election meeting of the shareholders of the Corporation ended on October 15th, 2010.
04/18/2010 Geneblue Annual shareholder is successfully held on 16th April, 2010. Details of the decision will be anounced as soon as meeting document preparation is completed.
04/12/2010 Geneblue annual Shareholder is ON SCHEDULE April 16 2010.
03/30/2010 Geneblue Annual Shareholder Meeting to be held on April 16, 2010
10/22/2008 GBH Drug Shows Promising Outcome!
9/24/2008 GBH Drug- A New Drug for Breast Cancer?
5/6/2008 GBH Meeting Held in Beijing Today
1/21/2008 GB sponsors Keystone Symposia Meeting

Geneblue Board of Directors re-elected October 15th, 2010. The shareholder initiated re-election meeting of the shareholders of the Corporation ended on October 15th, 2010.